These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19692647)

  • 1. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.
    Wolf AM; Eller K; Zeiser R; Dürr C; Gerlach UV; Sixt M; Markut L; Gastl G; Rosenkranz AR; Wolf D
    J Immunol; 2009 Sep; 183(6):3751-60. PubMed ID: 19692647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
    Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
    Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
    Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
    Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice.
    Sun Y; Wang W; Shan B; Di J; Chen L; Ren L; Li W; Li DJ; Lin Y
    Am J Reprod Immunol; 2011 Nov; 66(5):349-62. PubMed ID: 21623989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of experimental autoimmune uveitis in mice treated with FTY720.
    Commodaro AG; Peron JP; Lopes CT; Arslanian C; Belfort R; Rizzo LV; Bueno V
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2568-74. PubMed ID: 20019358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
    Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
    Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
    J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival.
    Heng Y; Ma Y; Yin H; Duan L; Xiong P; Xu Y; Feng W; Fang M; Tan Z; Chen Y; Zheng F; Gong F
    Transpl Int; 2010 Dec; 23(12):1259-70. PubMed ID: 20536794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.
    Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V
    Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.
    Fujii R; Kanai T; Nemoto Y; Makita S; Oshima S; Okamoto R; Tsuchiya K; Totsuka T; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G267-74. PubMed ID: 16574986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
    Hofmann M; Brinkmann V; Zerwes HG
    Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.